Millioni Chhabra, a scientist working on finding cure for HIV in North Carolina USA

Investors Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development

Dr Hal Barron, GSK
Dr Hal Barron

On 8 November 2017, we announced that Dr Hal Barron has been appointed Chief Scientific Officer and President, R&D. He has also been appointed as an Executive Director to the GSK Board.

Dr Barron will assume his new role and join the Board on 1 January 2018.

Read more

Latest information

Annual Report and Responsible Business Supplement 2016

View our Annual Report 2016 summary and download the full Annual Report and Responsible Business Supplement.